European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)

/PRNewswire/ -- GC Biopharma Corp. (006280.KS) announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its...

Related Keywords

South Korea ,Yelin Jun ,Rachel Kim ,Sohee Kim ,European Medicines Agency ,Gc Biopharma Corp ,Prnewswire Gc Biopharma Corp ,Green Cross Corporation ,Orphan Drug Designation ,Enzyme Replacement Therapy ,Sanfilippo Syndrome ,Rare Pediatric Disease ,Novel Pharma ,Gc Biopharma ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Fda Approval ,International Medical Approval ,